Related Experiment Video

Updated: Feb 24, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K

Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours

H Yurugi, F Marini, C Weber

    Oncogene
    |August 29, 2017
    PubMed

    Insights

    This study corrects a previously published article DOI. The correction ensures accurate citation and referencing for future research in the field.

    Area of Science:

    • Scientific publishing
    • Research integrity

    Background:

    • Accurate citation is crucial for scientific reproducibility.
    • Maintaining the integrity of the scientific record is paramount.

    Purpose of the Study:

    • To provide a correction for a specific article DOI.
    • To ensure the scientific literature is accurate and reliable.

    Main Methods:

    • Correction of the Digital Object Identifier (DOI).

    Main Results:

    • The article DOI has been updated to 10.1038/onc.2017.93.
    • Ensured accurate linkage to the published research.

    Conclusions:

    • This correction upholds the standards of scientific communication.
    • Facilitates correct access and citation of the research article.

    More Related Videos

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging04:43

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

    Published on: February 27, 2020

    7.4K
    Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

    Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

    Published on: October 17, 2025

    574

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.0K
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    6.1K
    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
    13.3K